Articles From: WuXi Launches Mobile App to Enable Chemistry-on-the-Go to Alliance Data Announces New Stock Repurchase Program


2015/1/5
SHANGHAI , Jan.
Sign-up for WuXi Launches Mobile App to Enable Chemistry-on-the-Go investment picks
2015/1/5
BETHESDA, Md.
Sign-up for Walker & Dunlop Announces New Loan Origination Team in Denver, Colorado investment picks
2015/1/5
Bristol-Myers Squibb Company (NYSE:BMY) and the California Institute for Biomedical Research (Calibr) announced today they have entered into a worldwide research collaboration to develop novel small molecule anti-fibrotic therapies, and an exclusive license agreement that allows Bristol-Myers Squibb to develop, manufacture and commercialize Calibr’s preclinical compounds resulting from the collaboration.
Sign-up for Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) Sign Worldwide Research Collaboration and License Agreement Focused on New Treatment Approaches for Fibrotic Diseases investment picks
2015/1/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167238&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Ideal Power Wins Critical European Patent for Its Core Power Packet Switching Architecture (PPSA) Power Conversion Technology investment picks
2015/1/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166971&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for AMD Embedded G-Series SoC Accelerates New QNAP NAS System investment picks
2015/1/5
REDWOOD CITY, Calif.
Sign-up for Genomic Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/5
BRANFORD, Conn., Jan.
Sign-up for CASMED Appoints Paul Molloy to Its Board of Directors investment picks
2015/1/5
Avnet, Inc.(NYSE: AVT), a leading global technology distributor, today announced that it has promoted Patrick Zammit to serve as global president for Avnet Technology Solutions, one of two global operating groups within Avnet.
Sign-up for Avnet Names Patrick Zammit Avnet Technology Solutions Global President investment picks
2015/1/5
COSTA MESA, Calif., Jan.
Sign-up for Start the New Year Off Right With El Pollo Loco's New Under 500 Calorie Menu Items investment picks
2015/1/5
HOUSTON , Jan.
Sign-up for Omega Protein To Present At The 17th Annual ICR XChange Conference investment picks
2015/1/5
Highly-acclaimed leader in ophthalmology adds clinical expertise to Board SAN DIEGO , Jan.
Sign-up for Imprimis Pharmaceuticals Appoints Dr. Richard L. Lindstrom to its Board of Directors investment picks
2015/1/5
TEL AVIV, Israel , Jan.
Sign-up for Galmed Pharmaceuticals Announces the Appointment of Josh Blacher as Chief Financial Officer investment picks
2015/1/5
JACKSONVILLE, Fla., Jan.
Sign-up for Stein Mart, Inc. to Present at 17th Annual ICR XChange Conference investment picks
2015/1/5
Alnylam Pharmaceuticals , Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Swedish Medical Products Agency (MPA) to initiate a Phase 1 clinical trial with ALN-AS1, a subcutaneously administered investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 (ALAS-1) for the treatment of hepatic porphyrias, including acute intermittent porphyria (AIP). Per the filed CTA, the Phase 1 trial of ALN-AS1 will be performed first in AIP patients who are asymptomatic “high excreters” (ASHE) – patients with a mutation in the porphobilinogen deaminase (PBGD) gene and elevated urinary aminolevulinic acid (ALA) and porphobilinogen (PBG) levels, but no recent symptoms of a porphyria attack – and then in AIP patients who experience recurrent porphyria attacks.
Sign-up for Alnylam Files Clinical Trial Application to Initiate a Phase 1 Study for ALN-AS1, a Subcutaneously Administered, Investigational RNAi Therapeutic Targeting Aminolevulinic Acid Synthase-1 (ALAS-1) for the Treatment of Hepatic Porphyrias investment picks
2015/1/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167295&ProfileId=051205&sourceType=1 PHOENIX, AZ --
Sign-up for Insys Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/5
World Fuel Services Corporation (NYSE: INT) today announced that it has appointed Jorge L.
Sign-up for World Fuel Services Corporation Names Jorge L. Benitez to the Board of Directors investment picks
2015/1/5
Kofax ® Limited (NASDAQ: KFX)(LSE: KFX), a leading provider of software to simplify and transform the First Mile™ of customer engagement, today announced Chief Executive Officer Reynolds C.
Sign-up for Kofax to Present at Needham Growth Conference investment picks
2015/1/5
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the 33 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, at 9:30 a.m. Pacific Standard Time at the Westin St.
Sign-up for Lannett to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 14 investment picks
2015/1/5
Cerus Corporation (NASDAQ:CERS) announced today that its European Phase 3 clinical trial of red blood cells treated with the INTERCEPT Blood System for acute anemia in cardiovascular surgery patients met the primary endpoint.
Sign-up for Cerus Reports EU Phase 3 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint investment picks
2015/1/5
RUTHERFORD, N.J., Jan.
Sign-up for Cancer Genetics, Inc. Receives Approval to Provide Oncology Testing for Patients in California investment picks
2015/1/5
HOUSTON , Jan.
Sign-up for Cameron Completes Sale Of Centrifugal Compression Business investment picks
2015/1/5
McDermott International, Inc. (NYSE:MDR) (“McDermott”) announced today that it has been awarded a contract to install the offshore jacket, deck and piles for the Ayatsil-A drilling platform for PEMEX Exploracion y Produccion (“PEMEX”) in the Bay of Campeche Ayatsil field.
Sign-up for McDermott Awarded Bay of Campeche Ayatsil-A Installation Contract for PEMEX investment picks
2015/1/5
BEIJING, Jan.
Sign-up for ChinaNet Online Announces Appointment of Independent Director investment picks
2015/1/5
RADNOR, Pa.
Sign-up for Zynerba Pharmaceuticals Appoints Richard A. Baron VP and CFO investment picks
2015/1/5
TORONTO, Jan.
Sign-up for SunOpta Scheduled to Attend the 17th Annual ICR XChange on January 13, 2015 investment picks
2015/1/5
J. Braxton Carter, Executive Vice President and Chief Financial Officer, and Neville R.
Sign-up for T-Mobile US, Inc. to Present at the 2015 Citi Internet, Media & Telecommunications Conference investment picks
2015/1/5
LANGHORNE, Pa., Jan.
Sign-up for Alliqua BioMedical Announces Group Purchasing Agreement With Premier, Inc. investment picks
2015/1/5
$600 Million Available for Repurchases during 2015 DALLAS , Jan.
Sign-up for Alliance Data Announces New Stock Repurchase Program investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: WuXi Launches Mobile App to Enable Chemistry-on-the-Go to Alliance Data Announces New Stock Repurchase Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent